Resveratrol (Figure 6D) has anti-tumor effects in breast cancers through blocking N-glycosylation and promoting dimerization of PD-L1, thus reducing N-glycosylation-mediated interaction with PD-1 [18,88]. The gene discussed is PDCD1; the disease is neoplasm.